About Ra Chem Pharma
Ra Chem Pharma is a Healthcare company based in Hyderabad (India) founded in 1996 by Ravi K Yerra and J Rajender Rao, and was acquired by Advent International in July 2020. API and formulations are developed and manufactured under contract. The company has 1,138 employees. Ra Chem Pharma was last valued at $17.09 million in June 2013. Its Indian entity Ra Chem Pharma Limited reported revenue of βΉ621 Cr. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its competitors include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals; 1 of its 3 listed competitors has raised funding.
Company details
RA Chem Pharma is a contract developer manufacturer of API formulations. They provide bioanalytical services such as HPLC GC, synthesize impurities working standards. Their API products are duloxetine, venlafaxine, orlistat, itraconazole, etc. The company is specialized in formulations development of oral control release site-specific release deliveries for anti-spasmodic, non-steroidal anti-inflammatory, anti-anxieties alpha1 receptor blockers. The company also claims to have completed more than three hundred BABE studies for various regulatory agencies.
- Headquarters Hyderabad, India
- Employees 1,138
- Founders Ravi K Yerra, J Rajender Rao
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website rachempharma.com
- Social LinkedIn
- Acquired by Advent International (Jul 2020)
- Legal Name Ra Chem Pharma Limited
- Date of Incorporation 08 Jan, 1996
- Jurisdiction Hyderabad, Andhra Pradesh, India
- Annual Revenue₹621 Cr
FY 2021 · +15% YoY
- Net Profit₹77.80 Cr
FY 2021 · 13% margin
- EBITDA₹132 Cr
FY 2021 · 21% margin
- Latest Funding Round$339.58K (USD), Unspecified
Jun 2013
- InvestorsJoflo Industries
& 5 more
- Employee Count1,138
- Acquired by
Associated legal entities of Ra Chem Pharma
Ra Chem Pharma operates through Ra Chem Pharma Limited (amalgamated). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2021) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ra Chem Pharma Limited CIN U24110TG1996PLC022816 | Amalgamated | 08 Jan 1996 | Hyderabad, Andhra Pradesh | ₹621 Cr | 1,138 | 9 | View details |
Funding Insights of Ra Chem Pharma
- Total Rounds 4
- Last Round Unspecified β $339,584
- First Round $920,415
(Aug 2006)
- Investors Count 4
All 4 funding rounds of Ra Chem Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2013 | $339,584 | Unspecified | $17.09M | Ontario, Orchem International Trading | β |
| Oct 2011 | $805,972 | Unspecified | $12.53M | Ontario, Orchem International Trading | β |
| Sep 2008 | $1.71M | Unspecified | $β’β’β’β’β’ | Ontario, Orchem International Trading | |
| Aug 2006 | $920,415 | Unspecified | $β’β’β’β’β’ | Ontario, Laxmi RA |
| Date | Valuation | Stage |
|---|---|---|
| Jun 2013 | $17.09M | β’β’β’β’β’β’β’β’ |
| Oct 2011 | $12.53M | β’β’β’β’β’β’β’β’ |
| Sep 2008 | $β’β’β’β’β’ | β’β’β’β’β’β’β’β’ |
| Aug 2006 | $β’β’β’β’β’ | β’β’β’β’β’β’β’β’ |
Full valuation and stage history of Ra Chem Pharma
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $17.09M (Jun 2013). 6 investors in total: 6 institutional.
Investors in Ra Chem Pharma
Ra Chem Pharma has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Joflo Industries, Ontario and Orchem International Trading.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity firm focused on multiple sectors | adventinternational.com | Sao Paulo, Brazil | ||
Pharmaceutical products, medical instruments, and orthopaedic articles are wholesaled internationally. | Amsterdam, Netherlands | |||
Manufacturing of centrifuges for chemical and pharmaceutical sectors in India. | jofloindustries.com | Hyderabad, India | ||
Generics and API manufacturer | microlabsltd.com | Bengaluru, India |
Investor details for Ra Chem Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Ra Chem Pharma Limited (Ra Chem Pharma)
Ra Chem Pharma Limited is the primary company behind Ra Chem Pharma. The board of Ra Chem Pharma Limited currently have 7 directors; the longest-serving is Shweta Jalan, appointed in 2020. 24 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shweta Jalan DIN 00291675 | Director | 27 Oct 2020 | 6 yrs | Ra Chem Pharma Limited |
| Abhijit Mangalmoy Mukherjee DIN 08610857 | Director | 27 Oct 2020 | 6 yrs | Ra Chem Pharma Limited |
| Pankaj Patwari DIN 08206620 | Director | 27 Oct 2020 | 6 yrs | Ra Chem Pharma Limited |
| Bhaskar Vemban Iyer DIN 00480341 | Director | 27 Oct 2020 | 6 yrs | Ra Chem Pharma Limited |
| Venkatanaga Kali Vetukuri Vara Prasada Raju DIN 07267366 | Managing Director | 10 Mar 2021 | 5 yrs 8 mo | Ra Chem Pharma Limited |
| Jayant Bhalchandra Manmadkar DIN 03044559 | CFO | 16 Jul 2021 | 5 yrs 4 mo | Ra Chem Pharma Limited |
| Anil Kumar Chanana DIN 00466197 | Additional Director | 15 Dec 2021 | 4 yrs 11 mo | Ra Chem Pharma Limited |
People of Ra Chem Pharma
2 people are tracked at Ra Chem Pharma (2 in leadership); the tracked headcount is 1,138.
| Name | Role | Group |
|---|---|---|
Ravi K Yerra | Co-Founder & Executive Director | Leadership |
J Rajender Rao | Co-Founder | Leadership |
Complete people profiles for Ra Chem Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Ra Chem Pharma
Figures of Ra Chem Pharma Limited, the primary company behind Ra Chem Pharma, for FY 2021. Revenue was ₹621 Cr (+15% year on year). Net profit was ₹77.80 Cr (13% margin). EBITDA was ₹132 Cr (21% margin). Revenue has grown at a compounded annual rate of +12% over three years.
- ₹621 CrRevenue · FY 2021 · +15% YoY
- ₹77.80 CrNet profit · 13% margin
- ₹132 CrEBITDA · 21% margin
- ₹8.50 CrPaid-up capital
- 1,138Employees (provident fund records)
- +12%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Ra Chem Pharma Limited are on its company page.
Detailed financial statements for Ra Chem Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Ra Chem Pharma
6 dated milestones of Ra Chem Pharma across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Ra Chem Pharma is founded.
- Funding First funding round of $920K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Unspecified, of $340K.
- Exit Acquired by Micro Labs.
- Exit Acquired by Advent International.
Competitors of Ra Chem Pharma
Ra Chem Pharma has 3 listed competitors in our database, 1 of them funded. They include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indoco.com | 1947 | Mumbai, India | 6,291 | APIs manufacturing and formulation services are provided in therapeutic segments. | ||
| concordbiotech.com | 2000 | Ahmedabad, India | 1,598 | APIs and enzymes are manufactured through fermentation by the CDMO. | ||
| bdrpharma.com | 2003 | Mumbai, India | $88.16M | 1,864 | APIs and finished products are developed and manufactured. |
Detailed competitors of Ra Chem Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ra Chem Pharma
Websites that share an audience with Ra Chem Pharma (rachempharma.com).
Websites whose visitors overlap most with Ra Chem Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| indswiftlabs.com | 100% | 4.2K | #3,680,932 | View details | |
| vasudhapharma.com | 92% | 6.7K | #1,818,910 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Ra Chem Pharma (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 548 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ra Chem Pharma
Complete news archive for Ra Chem Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ra Chem Pharma
Ra Chem Pharma was founded in 1996 and raised its 1st funding round 10 years after it was founded.
Ra Chem Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Ra Chem Pharma has 1,138 employees.
The primary company behind Ra Chem Pharma, Ra Chem Pharma Limited, reported revenue of βΉ621 Cr for FY 2021, up 15% year on year.
RA Chem Pharma is a contract developer manufacturer of API formulations. They provide bioanalytical services such as HPLC GC, synthesize impurities working standards. Their API products are duloxetine, venlafaxine, orlistat, itraconazole, etc. The company is specialized in formulations development of oral control release site-specific release deliveries for anti-spasmodic, non-steroidal anti-inflammatory, anti-anxieties alpha1 receptor blockers. The company also claims to have completed more than three hundred BABE studies for various regulatory agencies.
Ra Chem Pharma's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Indoco Remedies.
Ra Chem Pharma has 6 investors. Key investors include Joflo Industries, Ontario, Orchem International Trading, Laxmi RA, and Advent International.
The valuation of Ra Chem Pharma is $17.09M as of Jun 2013.
Ra Chem Pharma operates through Ra Chem Pharma Limited.
Yes. Ra Chem Pharma was acquired by Advent International in July 2020.
The legal entities of Ra Chem Pharma currently have 8 directors, including Shweta Jalan, Abhijit Mangalmoy Mukherjee, Venkatanaga Kali Vetukuri Vara Prasada Raju and others.

